logo BDSP

Base documentaire

  1. Antidepressant drug use : Differences between psychiatrists and general practitioners : Results from a drug utilization observation study with fluoxetine.

    Article - En anglais

    Between 1990 and 1993, a series of drug utilization observation studies with fluoxetine (Flx) were conducted in Germany in several waves. 3,158 patients treated by psychiatrists/neurologists (PN) and 15,601 patients treated by general practitioners/internists (GPI) were included ; data collection at start and end of treatment focussed on diagnoses, symptoms, prescription, comedication, efficacy (CGI, Zung scale), and adverse events.

    Differences between PN and GPI patients were of major interest.

    For more than 90% of both the PN and the GPI cases, Flx was used for the indication of « depression », with a dosis of 20 mg/day.

    More PN patients (47%) than GPI patients (28%) were diagnosed as « endogenous » ; GPI patients more often presented with first episodes (36 vs. 24%), « suicidal ideation » was less prominent compared to PN subjects (17 vs. 28%). Psychotropic comedication was regarded as necessary in 39% (PN) and 10% (GPI) of the cases.

    Early treatment termination because of « remission/major improvement » was observed in 13% (PN) vs. 21% (GPI) and because of « adverse events » in 11% (PN) vs. 3% (GPI) of the patients.

    At observation end, 53% (PN) vs. 74% (GPI) were rated as « symptom-freelmarkedly improved » (CGI) ; self-ratings reflected comparable results, marked improvements over time, but still PN/GPI differences at the end. « Suicidality » related to depression was more pronounced in the PN group at both points in time. 24% (PN) vs. (...)

    Mots-clés Pascal : Etat dépressif, Trouble humeur, Prescription médicale, Fluoxétine, Inhibiteur recapture, Sérotonine, Antidépresseur, Psychotrope, Indication, Etude comparative, Psychiatre, Médecin généraliste, Allemagne, Europe, Homme

    Mots-clés Pascal anglais : Depression, Mood disorder, Medical prescription, Fluoxetine, Reuptake inhibitor, Serotonin, Antidepressant agent, Psychotropic, Indication, Comparative study, Psychiatrist, General practitioner, Germany, Europe, Human

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0120380

    Code Inist : 002B02B02. Création : 21/05/1997.